Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3075 of 3546 entries
View as:

Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT00725283 Org: User:
Start: 10/01/08 End: 06/22/16 Due: 06/22/17

Birth Defects Associated With Exposure to Lamotrigine in Pregnancy (EUROCAT)

Phase: N/A Priority: Normal
NCT ID: NCT01055327 Org: User:
Start: 05/31/09 End: 12/31/13 Due: 12/31/14

GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01245062 Org: User:
Start: 11/22/10 End: 12/16/16 Due: 12/16/17

Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PCV)-Free Liquid Compared to Rotarix Liquid Given in 2-doses in Healthy Chinese Infants Starting at Age 6-16 Weeks

Phase: N/A Priority: Normal
NCT ID: NCT06025695 Org: User:
Start: 09/01/23 End: 10/23/24 Due: 10/23/25

Glucagon-like Peptide (GLP) Utilization and Safety

Phase: N/A Priority: Normal
NCT ID: NCT01767389 Org: User:
Start: 09/30/12 End: 12/31/13 Due: 12/31/14

Japan Expansion Cohort: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT06868667 Org: User:
Start: 07/28/21 End: 06/19/26 Due: 06/19/27

Study to Identify and Characterize Bacteria Causing Acute Otitis Media in Young Children in Turkey

Phase: N/A Priority: Normal
NCT ID: NCT01031329 Org: User:
Start: 11/30/12 End: 02/28/14 Due: 02/28/15

Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01435915 Org: User:
Start: 06/28/10 End: 08/05/10 Due: 08/05/11

Effect of Fluoride in a Dentifrice on Remineralization of Erosive Lesions

Phase: N/A Priority: Normal
NCT ID: NCT01641237 Org: User:
Start: 03/31/12 End: 05/31/12 Due: 05/31/13

Dose-Ranging Study Of GSK233705B In Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00676052 Org: User:
Start: 05/16/08 End: 12/22/08 Due: 12/22/09

Bioequivalence Study of Albendazole 400 mg Tablets in Chinese Population

Phase: N/A Priority: Normal
NCT ID: NCT01755637 Org: User:
Start: 04/30/12 End: 06/30/12 Due: 06/30/13

A Study on the Reactogenicity, Safety and Immune Response of a Targeted Immunotherapy Against HSV in Healthy Japanese Participants Aged 18-40 Years

Phase: N/A Priority: Normal
NCT ID: NCT05989672 Org: User:
Start: 08/08/23 End: 04/24/24 Due: 04/24/25

Platform Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With aOX40 (GSK3174998) in Participants With RRMM

Phase: N/A Priority: Normal
NCT ID: NCT06160609 Org: User:
Start: 10/07/19 End: 01/09/23 Due: 01/09/24

Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS

Phase: N/A Priority: Normal
NCT ID: NCT00316732 Org: User:
Start: 10/25/04 End: 12/19/06 Due: 12/19/07

A Clinical Study to Evaluate a Stannous Fluoride Toothpaste for the Relief of Dentinal Hypersensitivity

Phase: N/A Priority: Normal
NCT ID: NCT03310268 Org: User:
Start: 11/18/17 End: 02/02/18 Due: 02/02/19

GSK1325756 Relative Bioavailability Study in Healthy Elderly Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03457727 Org: User:
Start: 03/07/18 End: 07/25/18 Due: 07/25/19

Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of GSK1070806 for the Prevention of Delayed Graft Function (DGF) in Adult Subjects After Renal Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT02723786 Org: User:
Start: 08/27/16 End: 03/06/18 Due: 03/06/19

A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD

Phase: N/A Priority: Normal
NCT ID: NCT01313637 Org: User:
Start: 03/01/11 End: 04/19/12 Due: 04/19/13

A First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK4528287 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06681181 Org: User:
Start: 11/18/24 End: 09/09/26 Due: 09/09/27

A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults

Phase: N/A Priority: Normal
NCT ID: NCT06431607 Org: User:
Start: 05/23/24 End: 06/06/25 Due: 06/06/26

Assess the Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00307541 Org: User:
Start: 10/27/05 End: 04/07/06 Due: 04/07/07

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Intravenous Single Dose and Repeat Dose of GSK3342830

Phase: N/A Priority: Normal
NCT ID: NCT02751424 Org: User:
Start: 06/13/16 End: 02/02/17 Due: 02/02/18

To Investigate the Effect of Intravenous Ondansetron on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01449188 Org: User:
Start: 08/16/11 End: 12/19/11 Due: 12/19/12

Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Phase: N/A Priority: Normal
NCT ID: NCT00540423 Org: User:
Start: 09/30/07 End: 12/31/08 Due: 12/31/09

A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a COVID-19 mRNA Vaccine in Adults Aged 50 Years and Above

Phase: N/A Priority: Normal
NCT ID: NCT06374394 Org: User:
Start: 04/29/24 End: 03/31/25 Due: 03/31/26